Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
![]() |
![]() |
|||||||
GSE130988 |
Capture-C analysis of RCC-susceptibility loci in 786O renal cancer cell line
|
2 | David Robert Mole | Dec 31, 2019 | ||||
GSE200203 |
ChIP-seq analysis of HIF-1a and HIF-2a binding in hypoxic cancer cell lines
|
16 | David Robert Mole | Nov 15, 2022 | ||||
GSE130989 |
ChIP-seq analysis of HIF-1b binding in hypoxic cancer cell lines
|
8 | David Robert Mole | Dec 31, 2019 | ||||
GSE130990 |
Co-incidence of RCC-susceptibility polymorphisms with HIF cis-acting sequences supports a pathway tuning model of cancer
|
10 | David Robert Mole | Dec 31, 2019 | ||||
GSE269819 |
Conserved patterns of transcriptional dysregulation, heterogeneity and cell states in clear cell kidney cancer [Bulk RNA-seq]
|
12 | David Robert Mole | Dec 18, 2024 | ||||
GSE269826 |
Conserved patterns of transcriptional dysregulation, heterogeneity and cell states in clear cell kidney cancer [scRNA-seq]
|
79 | David Robert Mole | Dec 18, 2024 | ||||
GSE206027 |
Expression profiling in RCC4/VHL cells under HIF and AHR co-activating conditions
|
24 | David Robert Mole | Jan 24, 2023 | ||||
GSE206028 |
Genome binding/occupancy profiling of HIF and AHR in RCC4 cells under co-activating conditions
|
91 | David Robert Mole | Jan 24, 2023 | ||||
GSE34871 |
Genome-wide mapping of HIF-2 binding in 786-O clear cell renal carcinoma cells
|
3 | David Robert Mole | Feb 01, 2012 | ||||
GSE200205 |
HIF-1a and HIF-2a ChIP-seq and RNA-seq of hypoxic cancer cell lines
|
40 | David Robert Mole | Nov 15, 2022 | ||||
GSE120887 |
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin
|
84 | David Robert Mole | Oct 06, 2018 | ||||
GSE120885 |
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (ChIP-seq)
|
66 | David Robert Mole | Oct 06, 2018 | ||||
GSE120886 |
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq)
|
18 | David Robert Mole | Oct 06, 2018 | ||||
GSE253168 |
Onocgenic cell marking and single-cell transcriptomics reveal cell type and time-resolved actions of von Hippel Lindau inactivation in the kidney
|
31 | David Robert Mole | Jan 16, 2024 | ||||
GSE206029 |
RCC4/VHL cells under HIF and AHR co-activating conditions
|
115 | David Robert Mole | Jan 24, 2023 | ||||
GSE200204 |
RNA-seq analysis of gene expression in normoxic and hypoxic cancer cell lines
|
24 | David Robert Mole | Nov 15, 2022 | ||||
GSE169041 |
SET1B facilitates activation of the hypoxia response through site-specific histone methylation
|
25 | David Robert Mole | Apr 30, 2021 | ||||
GSE159128 |
SET1B facilitates activation of the hypoxia response through site-specific histone methylation [ChIP-seq_1]
|
18 | David Robert Mole | Apr 30, 2021 | ||||
GSE169040 |
SET1B facilitates activation of the hypoxia response through site-specific histone methylation [ChIP-seq_2]
|
7 | David Robert Mole | Apr 30, 2021 | ||||
GSE200207 |
Single cell RNA-seq from primary ccRCC-patient-derived cell cultures on the 10X genomics platform
|
10 | David Robert Mole | Nov 15, 2022 |